Novo Nordisk A/S is the latest drug company to be challenged by U.S. Sen. Bernie Sanders (I–Vt.), who has made tilting at prescription drug prices …
Full story here.
Published by www.bioworld.com
Visited 1 times, 1 visit(s) today
Sanders demands 85% cut in Ozempic/Wegovy price – BioWorld
